News/announcements

 

Issue of shares and Total Voting Rights

Bioquell PLC announces that it has issued 5,087 Ordinary Shares of 10p each following the exercise of options under the Company's share option schemes.

Read more

PDMR Dealing, exercise of share options and issue of new ordinary shares

Bioquell PLC announces that it has issued 36,511 ordinary shares of 10p each following the exercise of options under the Company's share option and SAYE schemes. 

Read more

Directorate Change

Bioquell announces that it has accepted the resignation of Tony Bourne as a non-executive director, to take effect from the Company’s AGM on 26th April.

Read more

Directorate Change

Bioquell announces that it has accepted the resignation of Tony Bourne as a non-executive director, to take effect from the Company’s AGM on 26th April.

Read more

Notice of AGM 2017

The Annual General Meeting (“AGM”) of Bioquell PLC (“Bioquell” or “the Company”) will take place on Wednesday 26th April 2017 at the Company’s offices, 52 Royce Close, West Portway, Andover, Hampshire, SP10 3TS. The Meeting will start at 12.00 noon. The formal Notice of the AGM and the Form of Proxy are available for download – please follow the links below. 

Read more

Annual Report

Following the preliminary announcement issued on 7 March 2017, the full electronic version of the BIOQUELL annual report is now available to download in PDF format on the Company’s website at www.bioquellplc.com.

Read more

Purchase of own shares

Further to the Company’s announcement on 13 March 2017 stating its intention to reduce its capital by means of purchasing its shares from time to time using existing cash resources, the Company announces that on 13 March 2017 it purchased 25,000 of its ordinary shares on the London Stock Exchange at a price of 135 pence per share. The purchased shares will all be held as treasury shares.

Read more

Share Buyback Programme

Bioquell announces its intention to continue to reduce its capital by means of purchasing its ordinary shares from time to time ("Share Repurchases") using its existing cash resources, pursuant to the general authority given to it at the Company's General Meeting held on 20 June 2016 to make Share Repurchases totaling 3,438,415 million shares.

Read more

Bioquell PLC – 2016 Preliminary Results

Bioquell PLC (LSE symbol: BQE), the provider of specialist bio-decontamination systems and services to the international Life Sciences and Healthcare markets, today announces its preliminary results for the year ending 31st December 2016.

 

Read more

Share Buyback Programme

Share Buyback Programme
 
Bioquell announces its intention to reduce its capital by means of purchasing its shares from time to time ("Share Repurchases") using existing cash resources of up to £2.5 million, to make market purchases of up to 1,850,000 shares (the "Maximum Amount").  This amount is within the amount permitted pursuant to the general authority given to it at the Company's General Meeting held on 20 June 2016.  
 
By way of background, at the time of the tender offer which returned £40.8million to shareholders in June 2016 (the “Tender Offer”), the directors stated that should the number of ordinary shares validly tendered under the Tender Offer be less than the maximum permitted under the terms of the Tender Offer, subject to circumstances prevailing following completion of the Tender Offer, the Board intended to return any such balance to Shareholders by means of a market purchase through the London Stock Exchange. 

Read more